Epilepsy in multiple sclerosis.
D000293:Adolescent; D000328:Adult; D001463:Barbiturates / Q000627:therapeutic use; D001479:Basal Ganglia / Q000473:pathology; D002220:Carbamazepine / Q000627:therapeutic use; D002540:Cerebral Cortex / Q000473:pathology; D003711:Demyelinating Diseases / Q000473:pathology; D003975:Diazepam / Q000627:therapeutic use; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000150:complications* / Q000473:pathology; D010672:Phenytoin / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use
D001463:Barbiturates; D011324:Primidone; D002220:Carbamazepine; D010672:Phenytoin; D003975:Diazepam